RETRACTED – Influence of antidepressants on plasma levels of nitric oxide metabolites in patients with major depressive disorder

RETRACTED – Influence of antidepressants on plasma levels of nitric oxide metabolites in patients with major depressive disorder

The impairment of endothelial function by reduced endothelial production of nitric oxide (NO) may contribute to the increased risk of developing cardiovascular disease in patients with depression. NO also plays an essential role in the efficacy of antidepressants. The present study aimed to confirm...

Full description

Bibliographic Details
Main Authors:	Atsuko Ikenouchi, Naomichi Okamoto, Yusuke Konno, Rintaro Fujii, Yoshihisa Fujino, Reiji Yoshimura
Format:	Article
Language:	English
Published:	Cambridge University Press 2022-01-01
Series:	BJPsych Open
Subjects:	Depression nitric oxide antidepressants norepinephrine cardiovascular disease
Online Access:	https://www.cambridge.org/core/product/identifier/S2056472421010747/type/journal_article

Similar Items

Influence of antidepressants on plasma levels of nitric oxide metabolites in patients with major depressive disorder – RETRACTION
by: Atsuko Ikenouchi, et al.
Published: (2022-03-01)

The Molecular Mechanism of Exercise for Treatment of Patients with Major Depression: A Preliminary Report on the Dynamics of Metabolites of Nitric Oxide and Catecholamines
by: Atsuko Ikenouchi, et al.
Published: (2022-06-01)

Nitric Oxide Synthase Inhibitors as Antidepressants
by: Vallo Volke, et al.
Published: (2010-01-01)

Associations between plasma levels of C-reactive protein and catecholamine metabolites in patients with major depression
by: Reiji Yoshimura, et al.
Published: (2021-05-01)

Comparison of plasma catecholamine metabolites in melancholic and non-melancholic depression
by: Reiji Yoshimura, et al.
Published: (2022-09-01)

No interaction between plasma IL-6 and MHPG in major depression treated with paroxetine
by: Reiji Yoshimura, et al.
Published: (2022-09-01)

The Involvement of Nitric Oxide in Antidepressant-Like Effect of Metformin after Bile-Duct Ligation in NMRI Mice
by: Sattar Ostadhadi, et al.
Published: (2015-10-01)

Plasma levels of interleukin-6 and 3-methoxy-4-hydroxyphenylglycol and treatment with milnacipran in major depression
by: Reiji Yoshimura, et al.
Published: (2022-08-01)

A Metabolomics Study of Serum in Hospitalized Patients With Chronic Schizophrenia
by: Naomichi Okamoto, et al.
Published: (2021-12-01)

Expression of monoamine transporters, nitric oxide synthase 3 and neurotrophin genes in antidepressant-stimulated astrocytes
by: Sarah eKittel-Schneider, et al.
Published: (2012-04-01)

Effect of the personality traits of healthy Japanese workers on depressive symptoms and social adaptation, and on the achievement rate of exercise therapy to prevent major depression
by: Atsuko Ikenouchi, et al.
Published: (2023-06-01)

Tricyclic antidepressants, autonomic function and mortality in patients with coronary heart disease: data from the heart and soul study
by: Linn Kristina Kuehl, et al.
Published: (2012-09-01)

Design and Synthesis of Arylamidine Derivatives as Serotonin/Norepinephrine Dual Reuptake Inhibitors
by: Hui Wen, et al.
Published: (2019-01-01)

The Serum Brain-Derived Neurotrophic Factor Increases in Serotonin Reuptake Inhibitor Responders Patients with First-Episode, Drug-Naïve Major Depression
by: Reiji Yoshimura, et al.
Published: (2023-02-01)

Antidepressants /
by: Dudley, William, 1964-
Published: (2005)

Serotonin and norepinephrine reuptake inhibitor antidepressants: a look through the prism of their 30-year history
by: D. S. Danilov
Published: (2018-12-01)

Safety and tolerability of edivoxetine as adjunctive treatment to selective serotonin reuptake inhibitor antidepressants for patients with major depressive disorder
by: James M Martinez, et al.
Published: (2015-05-01)

Structural Changes in Hippocampal Subfields in Patients with Continuous Remission of Drug-Naive Major Depressive Disorder
by: Asuka Katsuki, et al.
Published: (2020-04-01)

Research progress of non-monoamine antidepressants
by: Huan Zhang, et al.
Published: (2021-12-01)

Monoaminergic Antidepressants in the Relief of Pain: Potential Therapeutic Utility of Triple Reuptake Inhibitors (TRIs)
by: Bruno P. Guiard, et al.
Published: (2011-01-01)

Fronto-striato network function is reduced in major depressive disorder
by: Reoto Kijima, et al.
Published: (2024-03-01)

The effect of antidepressant treatment on white matter integrity in Major Depression
by: S. Tourjman, et al.
Published: (2022-06-01)

The history of mianserin and mirtazapine: study of their neurochemical activity and determination of their position in the classification of antidepressants
by: D. S. Danilov, et al.
Published: (2020-04-01)

The nature and impact of antidepressant withdrawal symptoms and proposal of the Discriminatory Antidepressant Withdrawal Symptoms Scale (DAWSS)
by: Joanna Moncrieff, et al.
Published: (2024-04-01)

Comparison of Serum Metabolomics Pathways and Patterns between Patients with Major Depressive Disorder with and without Type 2 Diabetes Mellitus: An Exploratory Study
by: Naomichi Okamoto, et al.
Published: (2023-01-01)

Antidepressant use and risk of intubation or death in hospitalized patients with COVID-19: A retrospective cohort study of clinical effectiveness
by: Brian P. Brennan, et al.
Published: (2022-09-01)

Commentary: Meta-analysis overstates benefit of antidepressant combination therapy with α2-antagonists and reuptake inhibitors in major depression
by: Jonathan Henssler, et al.
Published: (2023-05-01)

Association between salivary mature brain‐derived neurotrophic factor and psychological distress in healthcare workers
by: Atsuko Ikenouchi, et al.
Published: (2023-12-01)

Gyrification patterns in first-episode, drug-naïve major depression: Associations with plasma levels of brain-derived neurotrophic factor and psychiatric symptoms
by: Tomoya Natsuyama, et al.
Published: (2023-01-01)

Antidepressants are an Important Part of Treating Depression
by: Jitender eSareen, et al.
Published: (2012-07-01)

The Ketamine Antidepressant Story: New Insights
by: Tahani K. Alshammari
Published: (2020-12-01)

Sialochemical Profile in Depressive Individuals under Antidepressant Therapy: An Observational Study
by: Umamaheswari Giri, et al.
Published: (2018-05-01)

Discontinuation of Antidepressants in Older Adults: A Literature Review
by: Romdhani A, et al.
Published: (2023-03-01)

Rapid response to antidepressants and correlation with response and remission after acute treatment
by: Fernando dos Santos Fernandes, et al.
Published: (2024-04-01)

Serum Extracellular Vesicle-Derived hsa-miR-2277-3p and hsa-miR-6813-3p Are Potential Biomarkers for Major Depression: A Preliminary Study
by: Issei Seki, et al.
Published: (2023-09-01)

Frequency of Compliance with Antidepressants using Antidepressant Compliance Questionnaire
by: Shahid Ali Khan, Muhammad Munir Ahmed, Imran Ahmed, Fareed Aslam Minhas
Published: (2012-12-01)

Women’s Perception and Attitude Towards Using Antidepressants During Pregnancy: A cross sectional study
by: S. Alshahrani
Published: (2022-06-01)

Effects of Antidepressant Treatment on Peripheral Biomarkers in Patients with Major Depressive Disorder (MDD)
by: Anna Mosiołek, et al.
Published: (2021-04-01)

Tricyclic antidepressants for major depressive disorder: a comprehensive evaluation of current practice in the Netherlands
by: Cornelis F. Vos, et al.
Published: (2021-10-01)

Challenging Received Wisdom: Antidepressants and the Placebo Effect
by: Irving Kirsch
Published: (2020-12-01)